SDHD mutations in head and neck paragangliomas result in destabilization of complex II in the mitochondrial respiratory chain with loss of enzymatic activity and abnormal mitochondrial morphology - PubMed (original) (raw)
SDHD mutations in head and neck paragangliomas result in destabilization of complex II in the mitochondrial respiratory chain with loss of enzymatic activity and abnormal mitochondrial morphology
P B Douwes Dekker et al. J Pathol. 2003 Nov.
Abstract
Hereditary head and neck paragangliomas are tumours associated with the autonomic nervous system. Recently, mutations in genes coding for subunits of mitochondrial complex II, succinate-ubiquinone-oxidoreductase (SDHB, SDHC, and SDHD), have been identified in the majority of hereditary tumours and a number of isolated cases. In addition, a fourth locus, PGL2, has been mapped to chromosome 11q13 in an isolated family. In order to characterize phenotypic effects of these mutations, the present study investigated the immunohistochemical expression of the catalytic subunits of complex II (flavoprotein and iron protein), SDH enzyme activity, and mitochondrial morphology in a series of 22 head and neck paragangliomas. These included 11 SDHD-, one SDHB-, two PGL2-linked tumours, and eight sporadic tumours. In the majority of the tumours (approximately 90%), the enzyme-histochemical SDH reaction was negative and immunohistochemistry of catalytic subunits of complex II showed reduced expression of iron protein and enhanced expression of flavoprotein. Ultrastructural examination revealed elevated numbers of tightly packed mitochondria with abnormal morphology in SDHD-linked and sporadic tumours. Immuno-electron microscopy showed localization of the flavoprotein on the remnants of the mitochondrial inner membranes, whereas virtually no signal for the iron protein was detected. These results indicate that the function of mitochondrial complex II is compromised in the majority of head and neck paragangliomas.
Copyright 2003 John Wiley & Sons, Ltd.
Similar articles
- Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility.
Astuti D, Hart-Holden N, Latif F, Lalloo F, Black GC, Lim C, Moran A, Grossman AB, Hodgson SV, Freemont A, Ramsden R, Eng C, Evans DG, Maher ER. Astuti D, et al. Clin Endocrinol (Oxf). 2003 Dec;59(6):728-33. doi: 10.1046/j.1365-2265.2003.01914.x. Clin Endocrinol (Oxf). 2003. PMID: 14974914 - Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas.
Benn DE, Croxson MS, Tucker K, Bambach CP, Richardson AL, Delbridge L, Pullan PT, Hammond J, Marsh DJ, Robinson BG. Benn DE, et al. Oncogene. 2003 Mar 6;22(9):1358-64. doi: 10.1038/sj.onc.1206300. Oncogene. 2003. PMID: 12618761 - Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma.
Bayley JP, van Minderhout I, Weiss MM, Jansen JC, Oomen PH, Menko FH, Pasini B, Ferrando B, Wong N, Alpert LC, Williams R, Blair E, Devilee P, Taschner PE. Bayley JP, et al. BMC Med Genet. 2006 Jan 11;7:1. doi: 10.1186/1471-2350-7-1. BMC Med Genet. 2006. PMID: 16405730 Free PMC article. - The genetics of paragangliomas: a review.
Martin TP, Irving RM, Maher ER. Martin TP, et al. Clin Otolaryngol. 2007 Feb;32(1):7-11. doi: 10.1111/j.1365-2273.2007.01378.x. Clin Otolaryngol. 2007. PMID: 17298303 Review. - Phenotypic dichotomy in mitochondrial complex II genetic disorders.
Baysal BE, Rubinstein WS, Taschner PE. Baysal BE, et al. J Mol Med (Berl). 2001 Sep;79(9):495-503. doi: 10.1007/s001090100267. J Mol Med (Berl). 2001. PMID: 11692162 Review.
Cited by
- Long-term in vitro 2D-culture of SDHB and SDHD-related human paragangliomas and pheochromocytomas.
Bayley JP, Rebel HG, Scheurwater K, Duesman D, Zhang J, Schiavi F, Korpershoek E, Jansen JC, Schepers A, Devilee P. Bayley JP, et al. PLoS One. 2022 Sep 30;17(9):e0274478. doi: 10.1371/journal.pone.0274478. eCollection 2022. PLoS One. 2022. PMID: 36178902 Free PMC article. - Loss of the SdhB, but Not the SdhA, subunit of complex II triggers reactive oxygen species-dependent hypoxia-inducible factor activation and tumorigenesis.
Guzy RD, Sharma B, Bell E, Chandel NS, Schumacker PT. Guzy RD, et al. Mol Cell Biol. 2008 Jan;28(2):718-31. doi: 10.1128/MCB.01338-07. Epub 2007 Oct 29. Mol Cell Biol. 2008. PMID: 17967865 Free PMC article. - The emerging role and targetability of the TCA cycle in cancer metabolism.
Anderson NM, Mucka P, Kern JG, Feng H. Anderson NM, et al. Protein Cell. 2018 Feb;9(2):216-237. doi: 10.1007/s13238-017-0451-1. Epub 2017 Jul 26. Protein Cell. 2018. PMID: 28748451 Free PMC article. Review. - The Dutch founder mutation SDHD.D92Y shows a reduced penetrance for the development of paragangliomas in a large multigenerational family.
Hensen EF, Jansen JC, Siemers MD, Oosterwijk JC, Vriends AH, Corssmit EP, Bayley JP, van der Mey AG, Cornelisse CJ, Devilee P. Hensen EF, et al. Eur J Hum Genet. 2010 Jan;18(1):62-6. doi: 10.1038/ejhg.2009.112. Eur J Hum Genet. 2010. PMID: 19584903 Free PMC article. - A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas.
Dahia PL, Ross KN, Wright ME, Hayashida CY, Santagata S, Barontini M, Kung AL, Sanso G, Powers JF, Tischler AS, Hodin R, Heitritter S, Moore F, Dluhy R, Sosa JA, Ocal IT, Benn DE, Marsh DJ, Robinson BG, Schneider K, Garber J, Arum SM, Korbonits M, Grossman A, Pigny P, Toledo SP, Nosé V, Li C, Stiles CD. Dahia PL, et al. PLoS Genet. 2005 Jul;1(1):72-80. doi: 10.1371/journal.pgen.0010008. Epub 2005 Jul 25. PLoS Genet. 2005. PMID: 16103922 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical